Intrinsic Value

The intrinsic value of Neurones SA (NE9) under the Base Case is 39.59 EUR per share. Compared with the current market price of 37.7 EUR, the stock appears Undervalued by 5% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

NE9 Intrinsic Value
€39.59
Undervaluation 5%
Intrinsic Value
Price €37.7

NE9 is valued in line with its history. A discount of this size has been typical over the past 5 years.

Monitor NE9
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €31.67
Get notified when the price drops into your buy zone
Intrinsic Value €39.59
Current Price €37.7
Margin of Safety 20% €31.67
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to NE9

Fundamental Analysis

What Neurones Does

Technology Information Technology

Neurones SA is a French IT services company that helps large businesses and public organizations run, modernize, and secure their information systems. It sells consulting and delivery work in areas such as application development, infrastructure management, data, cybersecurity, and digital workplace support. Its main customers are companies that need outside specialists to design, build, integrate, and maintain their software and IT environments.

Headquarters
France FR
Employees
7 099
IPO date
May 23, 2000
Read the full company overview
View Company Overview

Neurones has no economic moat

No Moat Narrow Wide

Neurones SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Neurones SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one NE9 stock?

The intrinsic value for Neurones SA (NE9) under the Base Case is 39.59 EUR.

Is NE9 stock undervalued or overvalued?

Compared with the current market price of 37.7 EUR, the stock appears Undervalued by 5% .

Back to Top